Results
196 patients met the inclusion criteria. 185 CMR studies were available. The median time from CMR study to CABG surgery was 2 (1, 4) days. The mean age of the study population was 63.2 years (± 11.5). Seventy-two percent were male. History of prior MI was present in 64% of patients and prior CABG in 5.4% patients. Median LV ejection fraction was 38% (28, 52). Cardiopulmonary bypass was used in 118 patients (72%).
There were 133 patients (72%) in the scar group and 52 patients (38%) in the No-scar group. Compared with No-scar group, Scar group has higher proportion of men 78% Vs 56% (p = 0.002), History of prior MI 74% Vs 39% (P = 0.0001) and lower LVEF 39% Vs 46 (P = 0.038).
Perfusion time (70 ± 19 min Vs 60 ± 15 min, P = 0.01) and Cross clamp time (48 ± 14 min Vs 40 ± 13 min, P = 0.004) were significantly longer in Scar group. In multivariate model, number of vessels bypassed (p < 0.0001), presence of scar (p = 0.0075), Age (p = 0.047) and lower LVEF (p = 0.049) were independently associated with longer perfusion time. Number of vessels bypassed (p < 0.0001), presence of scar (p = 0.0009) were independently associated with longer cross clamp time. There was no significant difference in 30-Day mortality, arrhythmia, duration of ventilation, prolonged ICU and hospital stay.
Conclusions
In patients undergoing surgical revascularization, presence of myocardial scar is significantly associated with longer perfusion and cross clamp time independent of traditional predictors. However, there is no significant difference in short term postoperative outcomes based on scar.
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